India-Russia-EAEU Pharma Axis Emerges as Strategic Power Bloc: Punia

• India, Russia, and the EAEU are forming a strategic pharmaceutical power bloc, driven by geopolitical shifts and Russia's push for medicine sovereignty.
• India, a leader in affordable generics, became Russia's largest medicine supplier in 2023, providing over 293 million pharmaceutical packages.
• Russia's Pharma-2030 strategy aims for strategic autonomy and encourages collaboration, moving from a consumer market to an emerging hub.
• The EAEU market (200 million consumers) offers simplified product registration for Indian companies, reducing time-to-market.
• The emerging model focuses on co-development and co-manufacturing, combining Russia's scientific base with India's manufacturing scale, especially after Western company withdrawals.

Why It Matters: The India-Russia-EAEU pharma axis creates strategic opportunities and shifts global power.